Bayer CropScience Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 5.20% vs 32.07% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 13.12% vs 49.27% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 18.79% vs 75.36% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -3.51% vs 16.33% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Bayer CropSci. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

1,100.80

671.49

429.31

63.93%

Other Operating Income

0.00

Total Operating income

1,100.80

671.49

429.31

63.93%

Raw Material Cost

892.70

415.93

476.77

114.63%

Purchase of Finished goods

31.90

39.48

-7.58

-19.20%

(Increase) / Decrease In Stocks

-367.70

-63.95

-303.75

-474.98%

Employee Cost

106.00

64.05

41.95

65.50%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

235.00

83.27

151.73

182.21%

Total Expenditure (Excl Depreciation)

897.90

538.78

359.12

66.65%

Operating Profit (PBDIT) excl Other Income

202.90

132.71

70.19

52.89%

Other Income

46.60

31.94

14.66

45.90%

Operating Profit (PBDIT)

249.50

164.65

84.85

51.53%

Interest

5.50

1.56

3.94

252.56%

Exceptional Items

0.00

Gross Profit (PBDT)

244.00

163.09

80.91

49.61%

Depreciation

37.60

15.95

21.65

135.74%

Profit Before Tax

206.40

147.13

59.27

40.28%

Tax

44.30

36.52

7.78

21.30%

Provisions and contingencies

0.00

Profit After Tax

162.10

110.61

51.49

46.55%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

162.10

110.61

51.49

46.55%

Equity Capital

44.90

499.15

-454.25

-91.00%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

36.10

2.22

33.88

1,526.13%

Diluted Earnings per share

36.07

2.22

33.85

1,524.77%

Operating Profit Margin (Excl OI)

18.43%

19.76%

0.00

-1.33%

Gross Profit Margin

22.17%

24.29%

0.00

-2.12%

PAT Margin

14.73%

16.47%

0.00

-1.74%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,100.80 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.49% vs -28.79% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 5.20% vs 32.07% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 162.10 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 69.38% vs -37.33% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 13.12% vs 49.27% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 202.90 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 73.27% vs -42.96% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 18.79% vs 75.36% in Mar 2025

Quarterly - Interest

Interest 5.50 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 5.77% vs 18.18% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -3.51% vs 16.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.43%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025